Answering some questions regarding Proton Pump Inhibitors
What Are PPIs?
Proton pump inhibitors (PPIs) are among the most commonly prescribed medications in the world. They include omeprazole (Prilosec), esomeprazole (Nexium), lansoprazole (Prevacid), pantoprazole (Protonix), and rabeprazole (Aciphex). PPIs work by blocking acid production in the stomach and are the most effective medications available for treating gastroesophageal reflux disease (GERD), stomach ulcers, and related conditions.
Why Is There Concern About Long-Term Use?
Over the past decade, a number of studies have made headlines linking PPIs to serious health problems — including kidney disease, bone fractures, dementia, heart disease, infections, and even cancer. These reports can be alarming, and it is understandable to have questions about whether it is safe to continue taking a PPI.
However, it is important to understand the quality of the evidence behind these reports and what the best available research actually shows.
What the Headlines Say vs. What the Science Shows
Most of the studies linking PPIs to serious side effects are "observational" studies. This means researchers looked at large groups of people who happened to be taking PPIs and noticed that some health problems occurred slightly more often in PPI users. However, these studies cannot prove that PPIs caused those problems. People who take PPIs tend to be older, have more medical conditions, and take more medications — all of which independently raise the risk of health issues. This makes it very difficult to separate the effect of the PPI from other factors.
The best type of study for determining whether a medication truly causes a side effect is a randomized controlled trial (RCT), in which some patients receive the medication and others receive a placebo (sugar pill), and outcomes are compared. A large, high-quality RCT studied over 17,000 patients taking pantoprazole or placebo for 3 years. The results were reassuring:
No significant increase in the risk of pneumonia, bone fractures, kidney disease, dementia, heart disease, cancer, or death was found with PPI use.
The only risk that was confirmed was a small increase in intestinal infections (such as those caused by bacteria like Salmonella or C. difficile) — 1.4% in PPI users compared to 1.0% in the placebo group.
A Closer Look at Specific Concerns
Bone Fractures
Some observational studies suggested PPIs might weaken bones. However, the large RCT found no increased fracture risk (odds ratio 0.96). Major medical societies do not recommend extra calcium, vitamin D, or bone density testing solely because someone takes a PPI.
Kidney Disease
Some studies reported a small association between PPIs and chronic kidney disease. The absolute increase in risk, if real, is estimated at about 0.1% to 0.3% per year. The RCT did not find a significant increase. Routine monitoring of kidney function is not recommended for PPI users who have no other kidney disease risk factors.
Dementia
Early studies raised concern, but newer and better-designed studies, as well as the large RCT, have not confirmed a meaningful link. The odds ratio from the RCT was 1.20, which was not statistically significant.
Heart Disease
Some studies suggested PPIs might increase cardiovascular risk, particularly in patients also taking blood thinners like clopidogrel (Plavix). However, the highest-quality evidence, including RCTs, has found no significant association between PPIs and heart attacks in the general population. For patients who take clopidogrel and have a strong need for a PPI, expert guidelines state the benefits of PPI therapy outweigh the theoretical cardiovascular risks.
Stomach Cancer
Some studies found a possible link between long-term PPI use and gastric cancer, particularly in people infected with H. pylori (a stomach bacteria). However, the RCT did not find an increased cancer risk with PPI use over 3 years. This remains an area of ongoing research.
Vitamin and Mineral Deficiencies
PPIs may modestly reduce absorption of vitamin B12 and magnesium. Routine monitoring of B12 levels is not recommended for PPI users who have no other risk factors for B12 deficiency. However, if you develop symptoms such as numbness, tingling, fatigue, or muscle cramps, mention these to your doctor.
Intestinal Infections
This is the one risk that has been confirmed in high-quality research. By reducing stomach acid, PPIs may allow certain bacteria to survive passage through the stomach. The risk is small but real. Good handwashing and food safety practices can help reduce this risk.
The Bottom Line
The American College of Gastroenterology (ACG) and the American Gastroenterological Association (AGA) agree on the following key points:
PPIs are the most effective medications for treating GERD and related conditions.
The well-established benefits of PPIs far outweigh their theoretical risks when used for appropriate reasons.
Most of the reported associations between PPIs and serious side effects appear to be the result of bias in observational studies and are not confirmed in higher-quality research.
PPIs should be used at the lowest effective dose for the shortest time needed — but for patients who truly need long-term therapy, continued use is considered safe.
There is no current recommendation for routine extra testing (bone density scans, blood tests for B12 or kidney function) solely because you take a PPI, unless you have other risk factors.
Additional reading/references:
Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors.
Proton Pump Inhibitors: Understanding the Associated Risks and Benefits of Long-Term Use.